MiroBio develops antibodies and variants to stimulate specific immune cell signals, allowing it to harness the natural control mechanisms of the immune system for therapeutic benefit across a range of diseases.
Company (Alive / Active)
Oxford, OX3 7FZ
England, United Kingdom
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)